Fundraising FoxBirk Venture — 2011 Investments
1 investments dated 2011 · listed companies and verified rows first · show all
APIM Therapeuticsapimtherapeutics.comNov 2011
APIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting peptide therapeutics that disrupt cellular stress responses and address treatment resistance in cancer.
BiotechHealthtech
Co-investorsSarsia Management AS
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.